Send feedback

PTEN p.Leu25=

c.75G>A · rs786201506 · VCV184505

Likely benign Expert panel
Classification
Likely benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 8 submitters
gnomAD v4.1
Rare
very rare (popmax 0.000254%, nfe)
Conditions
4
PTEN hamartoma tumor syndrome

ClinGen expert panel — PTEN VCEP

Likely Benign for PTEN hamartoma tumor syndrome. Applied ACMG criteria (verbatim):

PM2_Supporting BS3 BP7

Curation rationale (ClinGen, verbatim)

NM_000314.8(PTEN):c.75G>A (p.Leu25=) meets criteria to be classified as likely benign for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (ACMG Classification Rules Specified for PTEN Variant Curation version 3.0.0). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column). BS3: Synonymous variant with RNA, mini-gene, or other splicing assay demonstrating no splicing impact. (internal laboratory contributor) BP7: Variant is synonymous and no splicing impact is predicted. PM2_P: Absent in gnomAD. Using the Bayesian point system (PMID: 29300386) for this variant with conflicting evidence: 1 benign strong, 1 benign supporting and 1 pathogenic supporting codes get -4 + (-1) + 1 points; total is – 4 (likely benign).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 9.9GERP 1.9, phastCons 1
Overall
CADD14.84PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000254% European (non-Finnish) · 3/1,179,822 alleles
Filtering AF 6.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.9e-05%
Overall 0.000186% 3/1,613,824 alleles · very rare

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PTEN
Protein
p.Leu25=
Coding
c.75G>A
MANE Select
NM_000314
dbSNP
rs786201506
Type
single nucleotide variant
Location
chr10:87864544 (GRCh38)
Gene constraint
LOEUF 0.685 · pLI 0.05 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 83.76 · 12 PDB
Residue 25
a β-strand; the phosphatase tensin-type domain
Full PTEN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

PTEN hamartoma tumor syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: breast cancerCowden syndrome 1hereditary neoplastic syndrome

For PTEN hamartoma tumor syndrome (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-9 / 100 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pten-p-leu25 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown